Sign In
Labcorp Oklahoma, Inc.
Test Directory


Index:

Zika Virus IgM

Order Name Zika Virus IgM
Test Number: 6906641
Revision Date 12/12/2022
Test Name Methodology LOINC Code
Zika Virus IgM
Antibody Capture Chemiluminescence Immunoassay (CLIA) 80824-6 
Pregnant Yes/No
Prompt n/a 
Relevant Zika Exposure Yes/No
Prompt n/a 
Symptoms consistent with Zika Yes/No
Prompt n/a 
SPECIMEN REQUIREMENTS
Specimen Specimen Volume (min) Specimen Type Specimen Container Transport Environment
Preferred 2 mL (1 mL) Serum Clot Activator SST Refrigerated
Alternate 1 2 mL (1 mL) Serum Clot Activator (Red Top, No-Gel) Refrigerated
Instructions Specimen Type: Gel-barrier tube OR Red-Top tube OR Serum Transfer tube
Specimen Storage: Refrigerated
Specimen Collection: Blood collection aseptically by venipuncture. Samples should be allowed to clot and should be centrifuged and separated from the clot as soon as possible.
Special Instructions: Please refer to CDC guidance prior to submitting specimens for testing. This assay is intended for individuals meeting CDC Zika virus clinical criteria and/or CDC Zika virus epidemiological criteria. Specimens from symptomatic patients or returning travel
Specimen Stability: Room temperature: 24 hours; Refrigerated: 7 days; Frozen: >7 days Freeze/thaw cycles Stable x3 (stability provided by manufacturer or literature reference)
Prompt code: (6906645) Pregnant Y/N
Prompt code: (6906647) Relevant Zika Exposure Y/N
Prompt code: (6906649) Symptoms consistent with Zika Y/N
GENERAL INFORMATION
Expected TAT 2 - 5 days  
Clinical Use Use for patients whose symptoms began, or whose documented exposure occurred, at least 14 days prior to testing. Should also be used as followup for patients with negative serum and urine results from molecular testing performed less than 14 days after symptom onset. 
Performing Labcorp Test Code 163084 
Notes Labcorp Test Code: 163084
CPT Code(s) 86794
Lab Section Reference Lab